These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 13792796)
21. The use of sedative and stimulative drugs in emotional illness. BARTA FR Nebr State Med J; 1952 May; 37(5):144-8. PubMed ID: 14941116 [No Abstract] [Full Text] [Related]
22. The choice of drugs for disturbed psychiatric patients. COATES TF Va Med Mon (1918); 1953 Nov; 80(11):624-5. PubMed ID: 13102951 [No Abstract] [Full Text] [Related]
23. [Trial therapy with methylpentynol carbamate in ambulatory psychiatric treatment]. HELD R Sem Hop; 1956 Apr; 32(23):1326-33. PubMed ID: 13324245 [No Abstract] [Full Text] [Related]
24. Report on a new drug, captodiamine: a preliminary investigation. CASTNER CW; NOBLE RC Dis Nerv Syst; 1959 Dec; 20():594-6. PubMed ID: 13808321 [No Abstract] [Full Text] [Related]
25. Diethylammonium paraaminobenzoate in psychiatric practice. LANDRIANI F Gazz Med Ital; 1952 Oct; 111(10):269-72. PubMed ID: 13021413 [No Abstract] [Full Text] [Related]
27. Clinical evaluation of chlorhexadol, a new hypnotic. ROZETT O Dis Nerv Syst; 1961 Oct; 22():562-4. PubMed ID: 14494795 [No Abstract] [Full Text] [Related]
28. [Supporting therapy with neuroleptic preparations in conditions of a psychoneurological clinic]. KANEVSKAIA FO; TARASOV GK; TSUTSUL'KOVSKAIA MIa Zh Nevropatol Psikhiatr Im S S Korsakova; 1960; 60():242-7. PubMed ID: 14404299 [No Abstract] [Full Text] [Related]
29. [Therapeutic trial with SCTZ--a new hypnotic--in psychotic diseases]. OSTERMAN E; BELLANDER-LOFVENBERG S; LASSENIUS B Nord Med; 1959 Aug; 62():1191-3. PubMed ID: 14429302 [No Abstract] [Full Text] [Related]
30. [Effects of neuroleptic drugs on the crises and mental disorders of certain epileptics]. BONNET H Ann Med Psychol (Paris); 1956 Jul; 114(2):193-226. PubMed ID: 13340389 [No Abstract] [Full Text] [Related]
31. [Lysergic acid monoethylamide, a new ergot derivatives with sedative effect in psychiatric medication]. SOLMS H Schweiz Arch Neurol Psychiatr; 1954; 73(1-2):440-4. PubMed ID: 13195594 [No Abstract] [Full Text] [Related]
32. [Clinical study of R 1625 (haloperidol)]. HUMBEECK L Acta Neurol Psychiatr Belg; 1960 Jan; 60():75-81. PubMed ID: 14403976 [No Abstract] [Full Text] [Related]
33. [Clinical experimentation with R 1625 (haloperidol)]. KRISTJANSEN P Acta Neurol Psychiatr Belg; 1960 Jan; 60():82-5. PubMed ID: 14412052 [No Abstract] [Full Text] [Related]
34. [Results of 6 months of clinical experimentation with R 1625 (haloperidol)]. DE HAENE A Acta Neurol Psychiatr Belg; 1960 Jan; 60():58-62. PubMed ID: 13814779 [No Abstract] [Full Text] [Related]
36. [Clinical experimentation with haloperidol (R-1625) in psychiatry]. JACOBS R Acta Neurol Psychiatr Belg; 1960 Jun; 60():560-75. PubMed ID: 14406380 [No Abstract] [Full Text] [Related]
37. [Clinical aspects in 55 cases treated with haloperidol]. CHANTRAINE J; MEURICE E; PAIROUX R Acta Neurol Psychiatr Belg; 1960 Jan; 60():54-7. PubMed ID: 13809182 [No Abstract] [Full Text] [Related]
38. [Clinical experiences with a new neuroleptic drug (R 1625)]. CARDANI A; GOLDWURM GF Riv Sper Freniatr Med Leg Alien Ment; 1961 Mar; 85():231-63. PubMed ID: 13876491 [No Abstract] [Full Text] [Related]
39. [Observations on the use of R 1625]. LORET L Acta Neurol Psychiatr Belg; 1960 Jan; 60():86-90. PubMed ID: 14418311 [No Abstract] [Full Text] [Related]
40. Clinical trials of R 1625. GERLE B Acta Neurol Psychiatr Belg; 1960 Jan; 60():70-4. PubMed ID: 13827511 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]